This report contains market size and forecasts of Drug Delivery in Cancer in Global, including the following market information:
Global Drug Delivery in Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drug Delivery in Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug Delivery in Cancer include Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Delivery in Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Delivery in Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drug Delivery in Cancer Market Segment Percentages, by Type, 2021 (%)
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Global Drug Delivery in Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drug Delivery in Cancer Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinic
Cancer Treatment Centers
Others
Global Drug Delivery in Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drug Delivery in Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Delivery in Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drug Delivery in Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals